Last reviewed · How we verify

NCT04491305: EHP-5CRO

EHP-5 in Preoperative Assessment in Women With Endometriosis

Status unknown Last updated 29 July 2020
What this trial tests

trial testing Surgically treated women with endometriosis and confirmed diagnosis in Endometriosis in 100 participants. Status unknown.

Timeline
1 August 2020
Primary endpoint
1 August 2021
1 August 2021

Quick facts

Lead sponsorUniversity of Zagreb
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 August 2020
Primary completion1 August 2021
Estimated completion1 August 2021
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

University of Zagreb

Who can join

Adults 18 to 50, female only, with Endometriosis or Endometriosis Ovary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no validated tool in quality-of-life assessment of women with endometriosis in Croatia. First aim is to validate Endometriosis Health Profile-5 (EHP-5) before implementing this questionnaire in clinical practice. After validation, we will prospectively follow women with endometriosis through whole process - pre- and postoperatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other University of Zagreb trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04491305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing